Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 9, 2018

Primary Completion Date

March 19, 2021

Study Completion Date

March 19, 2021

Conditions

Becker Muscular Dystrophy

Interventions

DRUG

Givinostat

suspension of Givinostat (10 mg/mL)

DRUG

Placebo

suspension manufactured to mimic Givinostat

Trial Locations (2)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, UOS, Milan

Leiden University Medical Center LUMC, Leiden